MetaCap

InflaRx N.V. (IFRX) News

NASDAQ: IFRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.04-0.05 (-4.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IFRX news summary

We found 7 recent headlines mentioning InflaRx N.V. (IFRX): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, IFRX is down 4.59% at $1.04. The most recent story, "InflaRx Publishes First-In-Human Phase 1 Results For Izicopan; Stock Up", was published by Nasdaq on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest InflaRx N.V. headlines

Stocks mentioned alongside IFRX

Compare IFRX